CD19-targeted CAR T cells in refractory antisynthetase syndrome

被引:113
|
作者
Mueller, Fabian [1 ,2 ]
Boeltz, Sebastian [2 ,3 ]
Knitza, Johannes [2 ,3 ]
Aigner, Michael [1 ,2 ]
Voelkl, Simon [1 ,2 ]
Kharboutli, Soraya [1 ,2 ]
Reimann, Hannah [1 ,2 ]
Taubmann, Jule [2 ,3 ]
Kretschmann, Sascha [1 ,2 ]
Roesler, Wolf [1 ,2 ]
Manger, Bernhard [2 ,3 ]
Wacker, Jochen [2 ,3 ]
Mougiakakos, Dimitrios [7 ]
Jabari, Samir [4 ]
Schroeder, Rolf [4 ]
Uder, Michael [5 ,6 ]
Roemer, Frank [5 ,6 ]
Kroenke, Gerhard [2 ,3 ]
Mackensen, Andreas [1 ,2 ]
Schett, Georg [2 ,3 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med 5 Hematol & Oncol, D-91054 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Deutsch Zentrum Immuntherapie, D-91054 Erlangen, Germany
[3] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med 3 Rheumatol & Immunol, D-91054 Erlangen, Germany
[4] Friedrich Alexander Univ Erlangen Nurnberg, Inst Neuropathol, D-91054 Erlangen, Germany
[5] Friedrich Alexander Univ Erlangen Nurnberg, Inst Radiol, D-91054 Erlangen, Germany
[6] Univ Klinikum Erlangen, D-91054 Erlangen, Germany
[7] Otto von Guericke Univ, Dept Hematol & Oncol, Magdeburg, Germany
来源
LANCET | 2023年 / 401卷 / 10379期
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
D O I
10.1016/S0140-6736(23)00023-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:815 / 818
页数:4
相关论文
共 50 条
  • [41] Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
    Kansal, Rita
    Richardson, Noah
    Neeli, Indira
    Khawaja, Saleem
    Chamberlain, Damian
    Ghani, Marium
    Ghani, Qurat-ul-ain
    Balazs, Louisa
    Beranova-Giorgianni, Sarka
    Giorgianni, Francesco
    Kochenderfer, James N.
    Marion, Tony
    Albritton, Lorraine M.
    Radic, Marko
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (482)
  • [42] CD19-Targeted T Cells for Hematologic Malignancies Clinical Experience to Date
    Davila, Marco L.
    Sauter, Craig
    Brentjens, Renier
    CANCER JOURNAL, 2015, 21 (06): : 470 - 474
  • [43] Reverse fate mapping of CD19-targeted CAR T cells in patients with large B-cell lymphoma
    Good, Zinaida
    Hamilton, Mark P.
    Spiegel, Jay Y.
    Kurra, Sreevidya
    Desai, Moksha
    Prabhu, Snehit
    Yang, Eric
    Ozawa, Michael G.
    Hanson, Paul J.
    Wu, Fang
    Frank, Matthew J.
    Baird, John H.
    Muffly, Lori
    Claire, Gursharan K.
    Craig, Juliana
    Kong, Katherine A.
    Wagh, Dhananjay
    Coller, John
    Plevritis, Sylvia K.
    Sahaf, Bita
    Miklos, David B.
    Mackall, Crystal L.
    CANCER RESEARCH, 2022, 82 (12)
  • [44] CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).
    Newman, Haley
    Leahy, Allison Emily Barz
    Li, Yimei
    Liu, Hongyan
    Myers, Regina M.
    DiNofia, Amanda M.
    Dolan, Joseph Gregory
    Callahan, Colleen
    Devine, Kaitlin J.
    Wray, Lisa
    June, Carl H.
    Grupp, Stephan A.
    Rheingold, Susan R.
    Maude, Shannon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Effects of B Cell Depletion by CD19-targeted CAR-T Cells in a Murine Model of Systemic Sclerosis
    Avouac, Jerome
    Cauvet, Anne
    Orvain, Cindy
    Boulch, Morgane
    Bousso, Philippe
    Allanore, Yannick
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1882 - 1883
  • [46] Donor-derived CD19-targeted T cells in allogeneic transplants
    Magnani, Chiara Francesca
    Biondi, Andrea
    Biagi, Ettore
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 497 - 502
  • [47] Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Maude, Shannon L.
    Barrett, David M.
    Rheingold, Susan R.
    Aplenc, Richard
    Teachey, David T.
    Callahan, Colleen
    Baniewicz, Diane
    White, Claire
    Talekar, Mala K.
    Shaw, Pamela A.
    Brogdon, Jennifer L.
    Young, Regina M.
    Scholler, John
    Marcucci, Katherine T.
    Levine, Bruce L.
    Frey, Noelle
    Porter, David L.
    Lacey, Simon F.
    Melenhorst, J. Joseph
    June, Carl H.
    Grupp, Stephan A.
    BLOOD, 2016, 128 (22)
  • [48] Phase I Clinical Trial of Autologous CD19-Targeted 19-28z CAR T Cells in Adult Patients With Relapsed or Refractory B-ALL
    Park, Jae H.
    Riviere, Isabelle
    Wang, Xiuyan
    Bernal, Yvette
    Halton, Elizabeth
    Quintanilla, Hilda
    Curran, Kevin
    Sauter, Craig
    Sadelain, Michel
    Brentjens, Renier J.
    MOLECULAR THERAPY, 2015, 23 : S188 - S189
  • [49] Humoral Response to Pneumococcal Antigens Declines After CD19-targeted Car T Cell Therapy
    Lee, Dasom
    Jain, Michael
    Chavez, Julio
    Davila, Marco
    Khimani, Farhad
    Lazaryan, Aleksandr
    Pinilla, Javier
    Shah, Bijal
    Locke, Frederick
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 39 - 40
  • [50] A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
    Enblad, Gunilla
    Karlsson, Hannah
    Gammelgard, Gustav
    Wenthe, Jessica
    Lovgren, Tanja
    Amini, Rose Marie
    Wikstrom, Kristina I.
    Essand, Magnus
    Savoldo, Barbara
    Hallbook, Helene
    Hoglund, Martin
    Dotti, Gianpietro
    Brenner, Malcolm K.
    Hagberg, Hans
    Loskog, Angelica
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6185 - 6194